Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Jul 1;357(Pt 1):321–328. doi: 10.1042/0264-6021:3570321

Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

A M Aslanian 1, B S Fletcher 1, M S Kilberg 1
PMCID: PMC1221958  PMID: 11415466

Abstract

Childhood acute lymphoblastic leukaemia (ALL) is treated by combination chemotherapy with a number of drugs, always including the enzyme L-asparaginase (ASNase). Although the initial remission rate is quite high, relapse and associated drug resistance are a significant problem. In vitro studies have demonstrated increased asparagine synthetase (AS) expression in ASNase-resistant cells, which has led to the hypothesis that elevated AS activity permits drug-resistant survival. The data presented show that not only is elevated AS expression a property of ASNase-resistant MOLT-4 human leukaemia cells, but that short-term (12 h) treatment of the cells with ASNase causes a relatively rapid induction of AS expression. The results also document that the elevated expression of AS in ASNase-resistant cells is not fully reversible, even 6 weeks after ASNase removal from the culture medium. Furthermore, ASNase resistance, assessed as both drug-insensitive cell growth rates and decreased drug-induced apoptosis, parallels this irreversible AS expression. Mimicking the elevated AS activity in ASNase-resistant cells by overexpression of the human AS protein by stable retroviral transformation of parental MOLT4 cells is sufficient to induce the ASNase-resistance phenotype. These data document that ASNase resistance in ALL cells is a consequence of elevated AS expression and that although other drug-induced metabolic changes occur, they are secondary to the increased asparagine biosynthetic rate.

Full Text

The Full Text of this article is available as a PDF (243.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrulis I. L., Argonza R., Cairney A. E. Molecular and genetic characterization of human cell lines resistant to L-asparaginase and albizziin. Somat Cell Mol Genet. 1990 Jan;16(1):59–65. doi: 10.1007/BF01650480. [DOI] [PubMed] [Google Scholar]
  2. Andrulis I. L., Barrett M. T. DNA methylation patterns associated with asparagine synthetase expression in asparagine-overproducing and -auxotrophic cells. Mol Cell Biol. 1989 Jul;9(7):2922–2927. doi: 10.1128/mcb.9.7.2922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Asselin B. L., Ryan D., Frantz C. N., Bernal S. D., Leavitt P., Sallan S. E., Cohen H. J. In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Res. 1989 Aug 1;49(15):4363–4368. [PubMed] [Google Scholar]
  4. Baker B. W., Boettiger D., Spooncer E., Norton J. D. Efficient retroviral-mediated gene transfer into human B lymphoblastoid cells expressing mouse ecotropic viral receptor. Nucleic Acids Res. 1992 Oct 11;20(19):5234–5234. doi: 10.1093/nar/20.19.5234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Broome J. D. Studies on the mechanism of tumor inhibition by L-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells. J Exp Med. 1968 Jun 1;127(6):1055–1072. doi: 10.1084/jem.127.6.1055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bussolati O., Belletti S., Uggeri J., Gatti R., Orlandini G., Dall'Asta V., Gazzola G. C. Characterization of apoptotic phenomena induced by treatment with L-asparaginase in NIH3T3 cells. Exp Cell Res. 1995 Oct;220(2):283–291. doi: 10.1006/excr.1995.1317. [DOI] [PubMed] [Google Scholar]
  7. Codegoni A. M., Biondi A., Conter V., Masera G., Rambaldi A., D'Incalci M. Human monocytic leukemia expresses low levels of asparagine synthase and is potentially sensitive to L-asparaginase. Leukemia. 1995 Feb;9(2):360–361. [PubMed] [Google Scholar]
  8. Cortes J. E., Kantarjian H. M. Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer. 1995 Dec 15;76(12):2393–2417. doi: 10.1002/1097-0142(19951215)76:12<2393::aid-cncr2820761203>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  9. Gong S. S., Guerrini L., Basilico C. Regulation of asparagine synthetase gene expression by amino acid starvation. Mol Cell Biol. 1991 Dec;11(12):6059–6066. doi: 10.1128/mcb.11.12.6059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guerrini L., Gong S. S., Mangasarian K., Basilico C. Cis- and trans-acting elements involved in amino acid regulation of asparagine synthetase gene expression. Mol Cell Biol. 1993 Jun;13(6):3202–3212. doi: 10.1128/mcb.13.6.3202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haskell C. M., Canellos G. P. l-asparaginase resistance in human leukemia--asparagine synthetase. Biochem Pharmacol. 1969 Oct;18(10):2578–2580. doi: 10.1016/0006-2952(69)90375-x. [DOI] [PubMed] [Google Scholar]
  12. Hitoshi Y., Lorens J., Kitada S. I., Fisher J., LaBarge M., Ring H. Z., Francke U., Reed J. C., Kinoshita S., Nolan G. P. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 1998 Apr;8(4):461–471. doi: 10.1016/s1074-7613(00)80551-8. [DOI] [PubMed] [Google Scholar]
  13. Hudson M. M., Dahl G. V., Kalwinsky D. K., Pui C. H. Methotrexate plus L-asparaginase. An active combination for children with acute nonlymphocytic leukemia. Cancer. 1990 Jun 15;65(12):2615–2618. doi: 10.1002/1097-0142(19900615)65:12<2615::aid-cncr2820651202>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  14. Hutson R. G., Kilberg M. S. Cloning of rat asparagine synthetase and specificity of the amino acid-dependent control of its mRNA content. Biochem J. 1994 Dec 15;304(Pt 3):745–750. doi: 10.1042/bj3040745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hutson R. G., Kitoh T., Moraga Amador D. A., Cosic S., Schuster S. M., Kilberg M. S. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am J Physiol. 1997 May;272(5 Pt 1):C1691–C1699. doi: 10.1152/ajpcell.1997.272.5.C1691. [DOI] [PubMed] [Google Scholar]
  16. Iiboshi Y., Papst P. J., Hunger S. P., Terada N. L-Asparaginase inhibits the rapamycin-targeted signaling pathway. Biochem Biophys Res Commun. 1999 Jul 5;260(2):534–539. doi: 10.1006/bbrc.1999.0920. [DOI] [PubMed] [Google Scholar]
  17. Jaffe N., Traggis D., Das L., Moloney W. C., Hann H. W., Kim B. S., Nair R. L-asparaginase in the treatment of neoplastic diseases in children. Cancer Res. 1971 Jul;31(7):942–949. [PubMed] [Google Scholar]
  18. Kaspers G. J., Pieters R., Van Zantwijk C. H., Van Wering E. R., Van Der Does-Van Den Berg A., Veerman A. J. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood. 1998 Jul 1;92(1):259–266. [PubMed] [Google Scholar]
  19. Kaspers G. J., Veerman A. J., Pieters R., Van Zantwijk C. H., Smets L. A., Van Wering E. R., Van Der Does-Van Den Berg A. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood. 1997 Oct 1;90(7):2723–2729. [PubMed] [Google Scholar]
  20. Kiriyama Y., Kubota M., Takimoto T., Kitoh T., Tanizawa A., Akiyama Y., Mikawa H. Biochemical characterization of U937 cells resistant to L-asparaginase: the role of asparagine synthetase. Leukemia. 1989 Apr;3(4):294–297. [PubMed] [Google Scholar]
  21. Larson R. A., Dodge R. K., Burns C. P., Lee E. J., Stone R. M., Schulman P., Duggan D., Davey F. R., Sobol R. E., Frankel S. R. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood. 1995 Apr 15;85(8):2025–2037. [PubMed] [Google Scholar]
  22. Markwell M. A., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  23. Pieters R., Klumper E., Kaspers G. J., Veerman A. J. Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia. Crit Rev Oncol Hematol. 1997 Jan;25(1):11–26. doi: 10.1016/s1040-8428(96)00223-5. [DOI] [PubMed] [Google Scholar]
  24. Prager M. D., Bachynsky N. Asparagine synthetase in asparaginase resistant and susceptible mouse lymphomas. Biochem Biophys Res Commun. 1968 Apr 5;31(1):43–47. doi: 10.1016/0006-291x(68)90028-4. [DOI] [PubMed] [Google Scholar]
  25. Preti A., Kantarjian H. M. Management of adult acute lymphocytic leukemia: present issues and key challenges. J Clin Oncol. 1994 Jun;12(6):1312–1322. doi: 10.1200/JCO.1994.12.6.1312. [DOI] [PubMed] [Google Scholar]
  26. Story M. D., Voehringer D. W., Stephens L. C., Meyn R. E. L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharmacol. 1993;32(2):129–133. doi: 10.1007/BF00685615. [DOI] [PubMed] [Google Scholar]
  27. Sutow W. W., Garcia F., Starling K. A., Williams T. E., Lane D. M., Gehan E. A. L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group. Cancer. 1971 Oct;28(4):819–824. doi: 10.1002/1097-0142(1971)28:4<819::aid-cncr2820280403>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  28. Tallal L., Tan C., Oettgen H., Wollner N., McCarthy M., Helson L., Burchenal J., Karnofsky D., Murphy M. L. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer. 1970 Feb;25(2):306–320. doi: 10.1002/1097-0142(197002)25:2<306::aid-cncr2820250206>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  29. Waye M. M., Stanners C. P. Role of asparaginase synthetase and asparagyl-transfer RNA synthetase in the cell-killing activity of asparaginase in Chinese hamster ovary cell mutants. Cancer Res. 1981 Aug;41(8):3104–3106. [PubMed] [Google Scholar]
  30. Worton K. S., Kerbel R. S., Andrulis I. L. Hypomethylation and reactivation of the asparagine synthetase gene induced by L-asparaginase and ethyl methanesulfonate. Cancer Res. 1991 Feb 1;51(3):985–989. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES